This message was sent to ##Email##
|
| February 24, 2016 |
| |  | | |
|
|
|
Medical Economics
The Centers for Disease Control and Prevention (CDC) has updated its immunization schedule for adults, and it includes a number of changes including the addition of new options to fight serogroup B meningococcal disease and human papillomavirus.
The new guidance was developed by the Advisory Committee on Immunization Practices (ACIP), a branch of the CDC.
READ MORE
ASCT
Project Medishare for Haiti and the Haitian Ministry of Health are seeking volunteer histotechnologists to help train laboratory technologists in the basics of histotechnology and cytotechnology. Click here for more information.
| Date |
Event |
Location |
More information |
March 15, 2016
|
Pancreatic Cytology and the Papanicolaou Society of Cytopathology Guidelines: Impact and Issues
|
Your PC |
 Lester J. Layfield, MD
Professor and Chair, Department of Pathology and Anatomical Sciences
University of Missouri
Columbia, Missouri
|
More info |
Register
|
May 11, 2016
|
Error Reduction in the Cytopathology Laboratory |
Your PC |
 Kara Hansing, MEd, SCT(ASCP)
Cytotechnology Program Director
Mayo Clinic
Rochester, Minnesota
|
More info |
Register
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
Cancer Therapy Advisor
Not only may co-testing help prevent more cases of invasive cervical cancer compared with screening for only human papillomavirus, but it also may lower overall health care costs.
The clinical-economic modeling analysis was presented in poster form at the International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress in Milan. Co-testing, which uses both an mRNA-based HPV and a liquid-based Papanicolaou test in combination, provides “the benefit of better detection, more saved lives, and not only is it not cost adverse, but it's actually cost beneficial,” the study's lead author, Juan Felix, M.D., told Cancer Therapy Advisor.
READ MORE
Genetic Engineering & Biotechnology News
The human papillomavirus has been well established as an underlying cause of cervical cancer, but many researchers and public health organizations are beginning to take a much closer look at the virus' role in the increasing incidence of oropharyngeal (mouth and throat) cancer. A new study by researchers at The Johns Hopkins University suggests that at least one of the antibodies that are typically found in patients treated for oropharyngeal cancer could be useful in identifying those at risk for a recurrence of the disease.
READ MORE
Tech Times
Men are more at risk of developing mouth and throat cancer linked to oral sex, which can spread human papillomavirus, one of the most common sexually transmitted infections, which according to the U.S. Centers for Disease Control and Prevention affects more than 90 percent and 80 percent of sexually active men and women, respectively.
READ MORE
Health Canal
Manufacturers of the human papillomavirus (HPV) vaccine could reduce prices for low- and middle-income countries and still retain most profits, according to a new study published in the journal Health Affairs.
Researchers from the London School of Hygiene & Tropical Medicine and the World Health Organization created an economic model to assess the financial benefits of vaccinating 80% of the world’s 12-year old females against HPV, which is a cause of cervical cancer. They found that this could generate economic returns worth up to $12.5 billion a year.
READ MORE
News Medical
Researchers at Women & Infants Hospital, a Care New England hospital, recently published the results of a study demonstrating a connection between anal cancer and human papillomavirus infection.
The study — entitled "Anal Cytology and Human Papillomavirus Genotyping in Women with a History of Lower Genital Tract Neoplasia Compared with Low-Risk Women" — was published in a recent issue of the professional journal Obstetrics & Gynecology.
READ MORE
Science 2.0
When it comes to our immune system, dendritic cells serve as a sort of lighthouse for T-cells. These specialized immune cells break down cancer cells into smaller pieces known as antigens. Once this happens, they can signal white blood cells that are now able to recognize these matching antigens in cancer cells and respond appropriately.
READ MORE
CNBC
Terminally ill blood cancer patients have experienced complete remission following the introduction of a radical new treatment, scientists claim. Speaking at the annual meeting for the American Association for the Advancement for Science (AAAS), researcher Stanley Riddell said the results were unprecedented. "In the laboratory and in clinical trials, we are seeing dramatic responses in patients with tumors.
READ MORE
By Lynn Hetzler
 New point-of-care diagnostic testing could help doctors detect wound infection in less than a minute, according to a new study in Wound Repair and Regeneration. This new testing would present a vast improvement over the 24 hours it currently takes to plate and incubate bacteria. Point-of-care diagnostic testing has progressed rapidly in many areas of clinical practice. In the field of wound care, however, there is still significant need for rapid alternatives for bacterial identification.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
